James T. Treace

This profile gathers the share dealings of James T. Treace in Treace Medical Concepts, Inc., where the filings describe the role as board member. In total, 27 filings cover trades dated from 15 November 2021 to 15 August 2024.

Market trades split into 5 purchases (€1.3M) and 21 sales (€10.7M). Taken together, the sales exceed the purchases by €9.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2024, the count stands at 5 purchases and 1 sale.

In size, the median ticket on the buying side is €234k. On 5 out of 5 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 19 August 2024, the filings show an open-market purchase worth €457k in Treace Medical Concepts, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.